Clinical Trials
AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...
April 30, 2024 | News
AstraZeneca's ENHERTU Shows Breakthrough in Treating HR-Positive, HER2-Low Breast Cancer in Latest Trial
Positive high-level results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statis...
April 30, 2024 | News
Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...
April 30, 2024 | News
FDA Approves Ractigen Therapeutics' IND for Groundbreaking Bladder Cancer Therapy
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration...
April 29, 2024 | News
Onconic Therapeutics Gains South Korean Approval for Innovative GERD Treatment JAQBO
Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...
April 26, 2024 | News
Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy
The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...
April 26, 2024 | News
Naveris, Inc. Initiates Phase II Clinical Trial for HPV-Driven Head and Neck Cancer at MSKCC
-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of a Phase II clinical study in minimal ...
April 25, 2024 | News
Hanmi Pharmaceutical Partners with MSD to Advance Immuno-Oncology Drug BH3120 in New Clinical Trial
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...
April 24, 2024 | News
Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug
Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...
April 23, 2024 | News
Kintor Pharma Advances to Phase III with GT20029, Pioneering Topical Treatment for Male Androgenetic Alopecia
Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...
April 22, 2024 | News
GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...
April 22, 2024 | News
Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment
Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...
April 22, 2024 | News
YS Biopharma's New HBV Vaccine Gains Clinical Trial Approval in the Philippines
YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therap...
April 19, 2024 | News
Cognivia Secures Strategic Investment to Revolutionize Clinical Trials with AI
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly annou...
April 19, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
